Corcept Therapeutics Incorporated (CORT) ROE US GAAP (year values)

2020 2020 2021 2022 2023   LTM ? CAGR 5 years ?
ROE, % ? 20.3% 20.3% 29.9% 20.2% 20.9%   22.1%  
Changes by years, y/y, % -5pp 0pp +10pp -10pp +1pp     -5.2%

Corcept Therapeutics Incorporated. ROE, %

Corcept Therapeutics Incorporated. ROE, changes, pp

Corcept Therapeutics Incorporated (CORT) ROE US GAAP (quarter values)

2023Q3 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
ROE, % ? 19.8% 20.9% 21.5% 21.1% 22.1%   22.1%
Changes by years, y/y, % -5pp +1pp +4pp -1pp +2pp    
Changes by quarters, q/q, % -3pp +1pp +1pp 0pp +1pp    

Corcept Therapeutics Incorporated. ROE, %

Corcept Therapeutics Incorporated. ROE, changes, pp

Corcept Therapeutics Incorporated. ROE, changes, pp